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Abstract
Background: Francisella tularensis is the causative agent of tularemia and is classified as a Category A select agent. Recent
studies have implicated TLR2 as a critical element in the host protective response to F. tularensis infection, but questions
remain about whether TLR2 signaling dominates the response in all circumstances and with all species of Francisella and
whether F. tularensis PAMPs are predominantly recognized by TLR2/TLR1 or TLR2/TLR6. To address these questions, we have
explored the role of Toll-like receptors (TLRs) in the host response to infections with F. tularensis Live Vaccine Strain (LVS)
and F. tularensis subspecies (subsp.) novicida in vivo.
Methodology/Principal Findings: C57BL/6 (B6) control mice and TLR– or MyD88-deficient mice were infected intranasally
(i.n.) or intradermally (i.d.) with F. tularensis LVS or with F. tularensis subsp. novicida. B6 mice survived .21 days following
infection with LVS by both routes and survival of TLR1
2/2, TLR4
2/2, and TLR6
2/2 mice infected i.n. with LVS was equivalent
to controls. Survival of TLR2
2/2 and MyD88
2/2 mice, however, was significantly reduced compared to B6 mice, regardless of
the route of infection or the subspecies of F. tularensis. TLR2
2/2 and MyD88
2/2 mice also showed increased bacterial
burdens in lungs, liver, and spleen compared to controls following i.n. infection. Primary macrophages from MyD88
2/2 and
TLR2
2/2 mice were significantly impaired in the ability to secrete TNF and other pro-inflammatory cytokines upon ex vivo
infection with LVS. TNF expression was also impaired in vivo as demonstrated by analysis of bronchoalveolar lavage fluid
and by in situ immunofluorescent staining.
Conclusions/Significance: We conclude from these studies that TLR2 and MyD88, but not TLR4, play critical roles in the
innate immune response to F. tularensis infection regardless of the route of infection or the subspecies. Moreover, signaling
through TLR2 does not depend exclusively on TLR1 or TLR6 during F. tularensis LVS infection.
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Introduction
Francisella tularensis is a Gram-negative, coccobacillus that
replicates within macrophages, neutrophils, hepatocytes and type
II lung epithelial cells [1–5], and causes the zoonotic disease
tularemia in mammalian hosts [6]. Infection of humans occurs
naturally by exposure to infected animal carcasses, insect bites,
ingestion or inhalation. There are four subspecies (subsp.): tularensis
(type A), holarctica (type B), mediasiatica, and novicida. Subsp. tularensis
strains are highly virulent (LD50,10–100 CFU) [7,8], and cause
severe disease and death sporadically, predominantly in North
America. Subsp. holarctica strains cause a more widespread but less
severe disease in Northern Europe, Scandinavia and the former
Soviet Union. Subsp. novicida is highly attenuated for humans, and
is rarely isolated, but causes lethal disease in mice [9,10]. Because
of the high infectivity, virulence, and ability to be disseminated by
aerosol, F. tularensis type A and B strains have been classified as
Category A bioweapon agents [11]. A live attenuated vaccine
strain (derived from a subsp. holarctica strain and known as LVS)
was developed 50–60 years ago [12], but a lack of knowledge
about the mechanisms of attenuation and concerns about
reversion to virulence have prevented its licensure for use in the
U.S. [6,11]. Although LVS is attenuated in humans, it causes a
disease in mice that is very similar to human tularemia, and thus it
has been used extensively to model the human disease [13,14].
A hallmark of F. tularensis is its ability to infect, replicate and
survive within many cell types, including macrophages and
neutrophils (reviewed in [15]). The mechanisms used by F.
tularensis to evade host cellular defenses remain largely unknown
but appear to involve the abilities to escape the phagosome and
replicate in the cytoplasm [16–18], block the respiratory burst in
neutrophils [4], and suppress or delay inflammatory cytokine
production [2,19,20]. Most of what is known about the host
immune response to F. tularensis has come from studies in mice
infected intradermally (LD50 of ,10
6) or intraperitoneally
(LD50,10) with LVS [13,21], although recent studies have begun
to focus on pulmonary infection [22–24]. The emerging picture is
that the immune response to infection with F. tularensis involves
IFN-c- and TNF-mediated activation of resident macrophages
and recruited neutrophils that are important for controlling the
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+ and CD8
+ T cells that are required to
fully resolve the infection and produce long-term protective
immunity (reviewed in [14]). Recent evidence also supports a role
for the ASC/caspase-1/IL-1 axis in this infection [25]. The
mechanisms by which F. tularensis evades the host innate immune
response and rapidly replicates and disseminates to other organs to
establish systemic infection are unknown.
Innate immune responses are initiated as a result of recognition
by pattern recognition receptors (PRRs) of conserved molecules
expressed by many pathogens (pathogen-associated molecular
patterns or PAMPs). The Toll-like receptors (TLRs) are evolu-
tionarily conserved, germline-encoded PRRs that signal many
different cell types via a set of conserved signaling adaptors/
molecules that also participate in IL-1 receptor signaling (reviewed
in [26]). TLR signaling primarily activates the NF-kB and MAPK
signaling pathways, both of which play important roles in
inflammatory responses. The cytoplasmic domains of the TLRs
share a conserved domain with the IL-1 receptor known as the
Toll/IL-1 receptor (TIR) domain. This domain recruits other TIR
domain-containing adapter proteins, such as MyD88, that mediate
downstream signaling to activate pro-inflammatory gene expres-
sion. Certain TLRs form complexes with other accessory
molecules or form heterodimers with other TLRs. For example,
TLR2 dimerizes with either TLR1 or TLR6 to recognize
triacylated lipopeptides or diacylated lipopeptides, respectively
[27–30]. The PRRs that recognize F. tularensis PAMPs in vivo are
just beginning to be identified [31]. Recent in vivo studies have
indicated that TLR2 is critical for protection against intranasal
F. tularensis infection but not against intradermal infection [32,33].
Our studies demonstrate that TLR2 signaling via MyD88 plays an
important role in innate immune responses to F. tularensis infection
in vivo regardless of the route of infection and regardless of the
subspecies of F. tularensis. We also demonstrate that neither TLR1
nor TLR6 is exclusively required for TLR2-dependent recognition
of F. tularensis in vivo.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice, the Animal Welfare Act, the U.S. Public Health Service
Policy on Humane Care and Use of Laboratory Animals, and
‘‘Guide for the Care and Use of Laboratory Animals’’ published
by the National Research Council. All animal work was approved
by the University of Texas Health Science Center at San Antonio
Institutional Animal Care and Use Committee (protocol #
03062A-34-04-A,C).
Bacteria
The F. tularensis Live Vaccine Strain (LVS) (ATCC 29684),
originally derived from the fully virulent F. tularensis subsp. holarctica
[12], was provided by Dr. K. Elkins (Center for Biologics Research
and Evaluation, U.S. Food and Drug Administration, Bethesda,
MD). F. tularensis subsp. novicida strain U112, originally isolated
from a water sample in Utah [9,34], was obtained from Dr. Karl
Klose (University of Texas at San Antonio, San Antonio, TX).
LVS was grown at 37uC in tryptic soy broth supplemented with
1% IsoVitaleX (BD Diagnostic Systems, Sparks, MD) and subsp.
novicida was grown in the same medium plus 0.1% L-cystine.
Frozen stocks were stored in 40% glycerol at 280uC. Inocula for
infections of mice were prepared by first streaking a glycerol
bacterial stock on chocolate agar. After 72 h, bacterial colonies
were harvested and spread on chocolate agar to form a lawn. After
24 h, the lawn of bacterial growth was scraped from the plate and
thoroughly dispersed in tryptic soy broth containing the
appropriate supplements described above. Bacterial inocula
prepared in this way were stored at 4uC and used within 1 week
of preparation, during which the titer of viable bacteria was stable.
The titer of the inoculum used in a particular mouse infection was
determined by plating serial dilutions on chocolate agar plates on
the day of infection. All protocols were approved by the
Institutional Biosafety Committee at the University of Texas
Health Science Center at San Antonio.
Mice
C57BL/6 (B6) mice were obtained from the National Cancer
Institute (NCI-Frederick Animal Production Area, Frederick,
MD). B6129PF2/J hybrid mice (C57BL/66129P) were purchased
from The Jackson Laboratory (Bar Harbor, ME). TLR1
2/2 (N4)
[30], TLR2
2/2 (N4) [35], TLR4
2/2 (N4) [36], TLR6
2/2 (N5)
[37] and MyD88
2/2 (N4) [38] breeding pairs (all backcrossed for
4–5 generations onto the C57BL/6 genetic background) were
obtained under a materials transfer agreement from Dr. Shizuo
Akira (Osaka University, Osaka, Japan) via Dr. Douglas
Golenbock (University of Massachusetts Medical School, Worces-
ter, Mass.). Mice were used at 8–16 weeks of age in these studies.
Mice were bred and maintained in ventilated cages under specific
pathogen-free conditions in the University of Texas Health
Science Center at San Antonio Laboratory Animal Resources
Department, an AAALAC-accredited facility.
Mouse infection and determination of bacterial burden
Bacterial inoculum stocks were diluted in phosphate-buffered
saline (PBS) to the appropriate CFU/ml. Mice were anesthetized
lightly by intramuscular injection of a ketamine cocktail (30 mg/ml
ketamine, 4 mg/ml xylazine), and infected intranasally, or intra-
dermally at the base of the tail [21], with 20 ml of inoculum. The
serially diluted inoculum was immediately plated on chocolate agar
to determine the actual CFU/ml delivered for each experiment. To
measure bacterial burden, mice were sacrificed at 1, 3, 5 and 7 days
after intranasal (i.n.) infection, and the lungs, left lobe of liver and
spleen were removed aseptically and homogenized in 5 ml of PBS.
Ten-fold serial dilutions were prepared and plated on chocolate
agar and the number of CFU in each dilution was determined after
72 h of incubation at 37uC.
Mouse survival studies
Groups of mice were infected with F. tularensis LVS or subsp.
novicida as described above and monitored twice daily for 21 days
for signs of illness and death. Kaplan-Meier product-limit analysis
and Log Rank analysis of survival data was performed with
SigmaStat 3.1 software (Systat Software, Inc., Point Richmond,
CA). The Holm-Sidak multiple comparison method was used to
compare survival curves from all groups of mice, and a p value of
,0.05 was considered significant.
Bronchoalveolar lavage (BAL)
Mice were sacrificed and the tracheas were exposed through
midline incision and cannulated with a sterile 18-gauge BD
Angiocath
TM catheter (Becton Dickinson Infusion Therapy
Systems Inc., Sandy, UT). The lungs were lavaged serially with
1-ml aliquots of sterile lavage solution (PBS, 3 mM EDTA,
0.1 mM isoproterenol) for a total of 5 ml. The serial lavage
aliquots recovered from a single mouse were pooled (,4 ml) and
mixed with an equal volume of complete RPMI medium (RPMI
1640, 10% FBS, 2% penicillin-streptomycin, 2 mM L-glutamine,
1 mM sodium pyruvate, 100 mM non-essential amino acids,
TLRs and F. tularensis
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resulting supernatant (bronchoalveolar lavage fluid or BALF) was
stored at 280uC until use. BAL cells were washed twice with ice-
cold culture medium, and cell viability and concentration were
determined by staining with trypan blue (0.04%).
Proteose peptone-elicited peritoneal macrophages
Mice were injected intraperitoneally with 1 ml 10% (w/v)
proteose peptone (Fluka, BioChemika, Germany) and were
sacrificed 72 h later. Peritoneal cells were harvested by peritoneal
lavage with complete RPMI medium and seeded at 1610
6 cells/ml
into tissue culture dishes. Non-adherent cells were removed after
4 h by extensive washing with phosphate-buffered saline (PBS).
Adherent cells were incubated in complete RPMI medium at 37uC,
6% CO2 for another 24 h before use.
In vitro infections
Peritoneal macrophages or BAL cells were seeded in 96-well
culture plates (5610
4–1610
5 cells/well) and incubated in antibiot-
ic-free medium for 24 h at 37uC, 6% CO2 before use. Cells were
washed with complete RPMI medium and infected with LVS (MOI
of 80–120) or stimulated in parallel with E. coli LPS (10 mg/ml;
Sigma-Aldrich #L2360) in triplicate in 0.1–0.2 ml of antibiotic-free
medium for 4 h at 37uC, 6% CO2. Supernatants harvested from
infected cells were frozen at 280uC until use.
Cytokine assays
Cell culture supernatants or BALFs were thawed and assayed
using the BD
TM Cytometric Bead Array (CBA) Mouse Inflam-
mation kit (BD Biosciences, San Diego, CA) or by ELISA (BD
OptEIA
TM, BD Biosciences, San Diego, CA) according to the
manufacturers’ protocols. Analysis of sample data was performed
with BD
TM CBA Software or with SoftMaxH Pro 5 (Molecular
Devices, Sunnyvale, CA).
Immunofluorescence microscopy of frozen lung sections
Mice were infected intranasally with LVS and sacrificed at serial
time points. After perfusion with ice-cold PBS, separated lungs
were embedded in Tissue-Tek OCT compound and kept at
280uC. Lungs were sectioned at 9 mm by using a Shandon
Cryotome SME (Thermo Electron Corporation, Pittsburg, PA).
One in every five slides containing lung sections were fixed in
formalin for 10 min at room temperature (RT) and stained with
H&E to determine the state of the lung as well as the degree of cell
infiltration. The rest of the slides were air dried overnight and
fixed in fresh acetone for 20 sec at RT. Acetone fixed sections
were wrapped in aluminum foil and stored at 280uC. Frozen,
fixed lung sections were thawed at RT for 30 min, fixed at 220uC
in acetone followed by treatment with 70% ethanol and hydration
in PBS. Non-specific binding of antibody reagents was minimized
by incubating each slide for 30 min at RT with serum from the
same species from which the fluorochrome-conjugated antibodies
were derived. Lung sections were then incubated for 40 min with
primary antibodies diluted in species-specific serum at a
concentration that had been optimized previously. Lung sections
were washed 7 times for 3 min each and secondary antibodies
(when necessary) were applied and incubated for 30 min at RT.
Lung sections were analyzed for expression of TNF using purified
goat anti-mouse TNF (#AF-410-NA, R&D Systems, Minneapolis,
MN) followed by secondary rhodamine red X-conjugated
AffiniPure anti-goat IgG (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA), or for the presence of LVS using Alexa
488-conjugated mouse anti-LVS (provided by Dr. John Gunn,
Ohio State University Medical School). Stained sections were
mounted with fluorsave reagent (Calbiochem, La Jolla, CA)
containing 0.3 uM 49, 6-diamidino-2-phenylindole (DAPI), dilac-
tate (Molecular Probes, Eugene, OR). Fluorescence was visualized
with a Leica DMR epifluorescent microscope (Leica Microsys-
tems, Wetzlar Germany). Images were acquired using a cooled
CCD SPOT RT camera (Diagnostic Instruments Inc., Sterling
Heights, MI), and were processed and analyzed using Adobe
Photoshop 7.0 (Adobe Systems, Inc., Mountain View, CA).
Statistical analysis
All numerical data was presented as the mean+standard error of
the mean (SEM) or the median plus the 25
th and 75
th percentiles.
Significance among groups was determined using one-way
ANOVA followed by the Holm-Sidak method of post-hoc analysis
for normally distributed data. Alternatively, non-parametric
analysis was performed with the Kruskal-Wallis ANOVA on
ranks followed by Dunn’s post-hoc analysis for multiple compar-
isons. All statistical analyses were performed with SigmaStat3.1
software (San Jose, CA).
Results
MyD88
2/2 and TLR2
2/2 mice are more susceptible to
infection with F. tularensis regardless of the route of
infection or the subspecies
Several recent studies have reported a role for TLR2 in the
innate immune response to F. tularensis [32,33,39,39–42]. Of these,
the only two in vivo studies, one exploring an intranasal infection
model in mouse [32] and the other an intradermal model [33],
came to different conclusions regarding the TLR2-dependence of
mouse susceptibility to F. tularensis LVS infection. We have studied
the role of TLRs and TLR signaling pathways in the host response
to F. tularensis infection in vivo following intranasal (i.n.) or
intradermal (i.d.) infection with F. tularensis. Initially, groups of
TLR2
2/2, TLR4
2/2 or MyD88
2/2 mice were infected intrana-
sally with the LVS strain of F. tularensis subsp. holarctica. Control
groups of C57BL/6 (B6) mice and B6129PF2 hybrid mice were
also infected in parallel. Mice were observed for 21 days to
determine morbidity and mortality. Figure 1A and 1B demon-
strate that all but one B6 and all B6129PF2 mice survived when
infected with LVS intranasally (,1L D 50), although all mice
became obviously ill. The clinical course and survival of TLR4
2/2
mice were indistinguishable from control mice (Figure 1B).
TLR2
2/2 and MyD88
2/2 mice, however, showed significantly
increased susceptibility to i.n. infection (Figure 1A and 1B). Eight
of ten TLR2
2/2 mice died by day 13 post-infection with a median
time-to-death (MTD) of 11.761.6 days. MyD88
2/2 mice had a
MTD of 7.760.2 days. To assess the influence of the route of
infection, we performed intradermal (i.d.) inoculations with a
sublethal dose of LVS (,1/40 of the LD50 in B6 mice [21]) and
monitored the mice for survival. Figure 1C and 1D show that
MyD88
2/2 and TLR2
2/2 mice infected intradermally also
demonstrate significantly reduced survival and increased mortality
rates compared to B6 controls, indicating that mouse survival is
dependent on TLR2 signaling regardless of the route of infection.
F. tularensis subsp. novicida is highly virulent in mice (LD50=,10)
[43] and also possesses a distinct and more endotoxic LPS than the
LVS strain [10]. We therefore tested whether the survival rate of
mice infected intranasally with the subsp. novicida would be
similarly dependent on TLR2 and not dependent on TLR4.
Figure 1E demonstrates that TLR2
2/2 and MyD88
2/2 mice
infected i.n. with 4 CFU of F. tularensis subsp. novicida were
significantly more susceptible to infection (MTDs of 861.5 days
TLRs and F. tularensis
PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e7920Figure 1. Survival of TLR
2/2 and MyD88
2/2 mice inoculated intranasally or intradermally with F. tularensis. Groups of mice (N, B6;
#, B6129PF2/J;¤, TLR2
2/2; %, TLR4
2/2; .,MyD88
2/2) were inoculated i.n. or i.d. with the indicated strains. The mice were monitored daily for 21
days for survival and signs of illness. Kaplan-Meier survival analyses were performed and survival was plotted as a function of time with each point
representing the cumulative probability of survival for the indicated group. Error bars represent the standard error for the cumulative probabilityo f
survival. Significant differences among groups were determined by Log Rank analysis and individual p values were calculated by the Holm-Sidek
method as described in Materials and Methods; p values of ,0.05 were considered significant. (A) The i.n. inoculum for B6 and TLR2
2/2 mice was
4,330 CFU of LVS; i.n. inoculum for B6129PF2/J mice was 6,183 CFU; n=10. One representative experiment is shown of two independent experiments
performed. *p=0.001. (B) The i.n. inoculum was 5,360 CFU of LVS, n=6. One representative experiment is shown of 2–4 independent experiments
performed. *p=0.001. (C) The i.d. inoculum was 38,680 CFU of LVS, n=10. *p=0.029. (D) The i.d. inoculum was 45,600 CFU, n=6. *p=0.055;
**p=0.001. (E) The i.n. inoculum was 4 CFU of F. tularensis subsp. novicida, n=6. *p=0.004; **p=0.004.
doi:10.1371/journal.pone.0007920.g001
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mice (MTD of .21 days), but the TLR4
2/2 mice (MTD of .21
days) are no more susceptible than control mice. Taken together,
these data indicate that TLR2 signaling, but not TLR4 signaling,
is critical for survival of infection with F. tularensis, regardless of
subspecies or route of infection. The increased susceptibility of
MyD88-deficient mice relative to TLR2
2/2 mice suggests that
additional MyD88-dependent pathways may also play essential
roles in the host response to this infection.
TLR2
2/2 and MyD88
2/2 mice are less able to control F.
tularensis LVS growth and dissemination
To determine whether the increased susceptibility of TLR2
2/2
and MyD88
2/2 mice to infection with F. tularensis was the result of
a failure to control bacterial growth and dissemination, the
bacterial burden in various organs was determined at different
times after intranasal infection with LVS. On days 1, 3, 5 and 7
post-infection, organs were removed from groups of infected mice
and viable bacterial counts were determined for the homogenized
tissues. No differences among the groups of mice were detected on
days 1 (data not shown) and 3 post-infection, except in the lungs of
MyD88-deficient mice in which median bacterial burden was
modestly higher on day 3 than in lungs of B6 mice (Figure 2). By
day 5, the median bacterial burdens in lungs, liver and spleen were
modestly higher in TLR2-deficient mice (although not statistically
significant) and were 3–4 logs higher in MyD88-deficient mice
compared to controls. By day 7, median bacterial burdens in
lungs, liver and spleen from TLR2
2/2 mice were 2–4 logs higher
than in organs from controls, but bacterial organ burdens could
not be determined for the day 7 post-infection group of MyD88
2/2
mice because the mice all died between days 6 and 7. Consistent
with the survival data, the bacterial burdens in the organs of
TLR4
2/2 mice were indistinguishable from those in control mice
(data not shown). These results suggest that the increased
susceptibility to pulmonary infection with F. tularensis in TLR2
2/2
and MyD88
2/2 mice results from a failure to limit bacterial
replication and dissemination.
Cytokine and chemokine responses to F. tularensis LVS
are impaired in macrophages isolated from TLR2
2/2 and
MyD88
2/2 mice
An important immune evasion mechanism for F. tularensis is its
ability to replicate and survive within macrophages [1]. Macro-
phages express both TLR2 and TLR4 and make early cytokine and
chemokine responses that play a critical role in innate immunity.
We therefore investigated the ability of F. tularensis to induce
cytokines and chemokines from primary mouse macrophages
derived from wild-type B6 mice and MyD88
2/2, TLR2
2/2,a n d
TLR4
2/2 mice. As a positive control, macrophages were
stimulated in parallel with E. coli LPS. Figure 3A (black bars) shows
that peritoneal macrophages from B6 mice respond to LVS
infection in vitro by producing increased amounts of TNF, IL-6
and MCP-1 relative to uninfected cells (,20 pg/ml). No IL-12p70,
or IFN-c were detected in these cultures (data not shown). By
contrast, peritoneal macrophages obtained from MyD88
2/2 mice
and TLR2
2/2 mice demonstrated profoundly impaired TNF, IL-6
and MCP-1 secretion in response to LVS infection compared to
macrophages from B6 mice. The failure of TLR2
2/2 and
MyD88
2/2 macrophages to produce proinflammatory cytokines
in response to LVS was not due to a general defect in the cells from
these mice because TLR2
2/2 macrophages secreted significant
levels of TNF, IL-6 and MCP-1, and MyD88
2/2 macrophages
secreted a significant level of RANTES, in response to E. coli LPS
(Figure 3A, gray bars). TNF, IL-6 and MCP-1 responses from
TLR4-deficient macrophages infected with LVS were similar to
those from wild-type macrophages (Figure 3A, black bars). We also
measured TNF secretionby cells obtained fromthe lungs of miceby
bronchoalveolar lavage. BAL cells from MyD88
2/2 and TLR2
2/2
mice failed to secrete TNF in response to in vitro infection with LVS
but cells from B6 and TLR4
2/2 mice made robust TNF responses
in vitro (Figure 3B). Similar results were observed in bone marrow-
derived macrophages and in macrophages infected with F. tularensis
subsp. novicida (data not shown). Interestingly, TNF, IL-6 and MCP-
1 responses to E. coli LPS were greater in TLR2-deficient peritoneal
macrophages than in control macrophages (Figure 3A, gray bars),
and TNF expression in response to LVS infection was greater in
TLR4-deficient alveolar macrophages than in B6 controls
(Figure 3B). Similar observations have been made by others [44],
but why this occurs is not known. It could be the result of increased
expression of one TLR in the absence of the other (e.g. increased
TLR4 in the absence of TLR2), increased availability of
downstream signaling molecules in the TLR-deficient cells, or
some other form of cross-regulation between these signaling
pathways.
TLR2
2/2 and MyD88
2/2 mice exhibit impaired in vivo
expression of cytokine and chemokine expression in the
lungs
To assess the role of TLRs in the inflammatory cytokine
response to F. tularensis infection in vivo, we analyzed proin-
flammatory cytokine expression in BAL fluid and performed in
situ immunofluorescent staining for TNF expression in the lungs
from mice infected intranasally with LVS. Analysis of BAL fluid
demonstrated a significant reduction in secretion of TNF in the
lungs of TLR2
2/2 and MyD88
2/2 mice compared to control
mice at 5 days post-infection (Figure 4A). Similar results were
obtained for IL-6 expression (data not shown). In situ TNF was
clearly detectable by day 3 post-infection in the lungs of B6 mice
(red stain in Figure 4B). No TNF expression could be detected
in the lung tissue of MyD88
2/2 mice, although bacteria were
detectable by day 1 (Figure 4B). In lung tissue from TLR2
2/2
mice, bacteria were detected as early as day 1, but TNF
expression was just barely detectable by day 5 post-infection
(Figure 4B). These results are consistent with the results of the in
vitro experiments described above and demonstrate that
inflammatory cytokine expression in vivo in the lungs in response
to LVS infection is impaired in mice deficient in MyD88 or
TLR2.
TLR1
2/2 and TLR6
2/2 mice are not more susceptible to
F. tularensis LVS infection than control mice
TLR2 is known to pair with either TLR1 or TLR6 in the
recognition of microbial ligands [27,30,45]. To investigate
whether TLR1 or TLR6 might be required with TLR2 for a
protective response to F. tularensis, survival experiments were
performed in TLR1
2/2 and TLR6
2/2 mice (Figure 5A). The
survival rate of these mice infected i.n. with LVS was
indistinguishable from the survival rate of control mice indicating
that neither TLR1 nor TLR6 is exclusively required for host
resistance to LVS infection. Macrophages harvested from
TLR1
2/2 and TLR6
2/2 mice expressed TNF, IL-6, MCP-1,
and IL-10 in response to LVS infection in vitro at comparable or
higher levels than B6 mice (Figure 5B). Thus, neither TLR1 nor
TLR6 are exclusively required for F. tularensis recognition by
TLR2.
TLRs and F. tularensis
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The results of this study confirm and extend a recent study that
demonstrated that TLR2 is critical for protection of mice against a
primary pulmonary infection with F. tularensis LVS [32]. However,
in contrast to a previous report [33], we show that the requirement
for TLR2 is independent of the route of infection, since TLR2
2/2
mice had significantly decreased survival rates compared to
Figure 2. Bacterial burdens in organs of mice following intranasal infection with F. tularensis LVS. Groups of mice (N, B6;¤, TLR2
2/2; .,
MyD88
2/2) were inoculated intranasally with 5000 CFU of LVS and viable bacterial counts were determined in the lungs, livers, and spleens at days 3,
5, and 7 post-infection as described in Materials and Methods. Each data point represents the total CFUs recovered per mg of tissue from the
indicated organs from an individual mouse. The median detectable CFU/mg of organ tissue in each group is indicated to the right of the symbols by
a horizontal tick mark and the 75
th (upper) and 25
th (lower) percentiles are also indicated. The data are representative of four independent
experiments. Significant differences among groups were determined by Kruskal-Wallis ANOVA on ranks as described in Materials and Methods; n=5
mice per time-point, *p,0.05 compared to B6 controls.
doi:10.1371/journal.pone.0007920.g002
TLRs and F. tularensis
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7920controls following infection by either the intranasal or the
intradermal route. MyD88 also contributes significantly to survival
of a primary pulmonary LVS infection, consistent with its reported
role in the intradermal infection [33]. The results of this study
further demonstrate that the host protective response to primary
infection with F. tularensis subsp. novicida is also dependent on
TLR2/MyD88 signaling. Importantly, TLR2
2/2 macrophages
are impaired in their ability to express pro-inflammatory cytokines
and chemokines in response to F. tularensis LVS infection and pro-
inflammatory cytokine expression is significantly impaired in vivo in
Figure 3. Cytokine and chemokine expression by primary macrophages in response to F. tularensis LVS infection. (A) Proteose
peptone-elicited peritoneal macrophages from B6, TLR2
2/2, TLR4
2/2, and MyD88
2/2 mice were infected with LVS (MOI of 120) or stimulated with E.
coli LPS (10 mg/ml) as indicated. Culture supernatants were collected after 4 h, and cytokines were quantified by BD
TM Cytometric Bead Array (CBA)
Mouse Inflammation Kit (BD Biosciences Pharmingen, San Diego, CA). The data are expressed as the average cytokine level (pg/ml) (+SEM) in
duplicate culture supernatants and are representative of 2–3 independent experiments. Significant differences among groups were determined by
one-way ANOVA followed by Holm-Sidek post-hoc analysis;
*p,0.01 compared to B6 macrophages infected with LVS,
#p,0.01 compared to B6
macrophages stimulated with E. coli LPS. Cytokine and chemokine levels in supernatants from mock-infected cells were ,20 pg/ml (data not shown).
(B) Alveolar macrophages harvested by bronchoalveolar lavage were infected with LVS (MOI of 80) and culture supernatants were collected at 4 h.
TNF expression was analyzed by ELISA as described in Materials and Methods. The data are expressed as the average TNF level (pg/ml) (+SEM) in
duplicate culture supernatants,
*p,0.01. TNF levels in supernatants from mock-infected cells were ,20 pg/ml (data not shown).
doi:10.1371/journal.pone.0007920.g003
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revealed that neither TLR1
2/2 nor TLR6
2/2 mice were any
more susceptible to LVS infection than control mice, although a
previous study reported an exclusive role for TLR6 in the pro-
inflammatory cytokine response of BM-derived dendritic cells to
LVS in vitro [39].
As stated above, our conclusion that TLR2
2/2 mice are more
susceptible to primary infection with LVS regardless of the route of
infection differs from conclusions drawn by Collazo et al. [33]. It
should be noted, however, that the survival rate reported by
Collazo et al. for i.d. LVS infection of TLR2
2/2 mice (68%,
n=19) is not very different from the overall survival rate of 56%
(n=16) observed in this study, suggesting that the somewhat
different results and the distinct conclusions may be due to
differences in the infectious doses given, or simply due to different
statistical treatment of the data. It is also important to point out
that in our studies, as well as those of Collazo et al., mice were
infected intradermally with doses of LVS that are significantly
below (1/40
th and 1/4
th, respectively) the reported i.d. LD50 for
B6 mice (,2610
6 CFU) [21]. It seems very likely therefore that
infection with higher doses of LVS would result in an even larger
difference in survival rates between control mice and TLR2
2/2
mice, as was observed by Malik et al. for intranasal LVS infections
[32], and supporting the conclusion that TLR2 is important in
both i.d. and i.n. infections. An accurate understanding of the role
of particular TLRs in host responses to infections by different
routes is important because of the implications for the rational
design of vaccine-enhancing adjuvants.
Although MyD88
2/2 and TLR2
2/2 mice both demonstrated
decreased survival rates compared to wild-type controls, the
MyD88
2/2 mice were significantly more susceptible to i.n. and
i.d. LVS infection than were the TLR2
2/2 mice. The reduced
survival time for the MyD88
2/2 mice also correlated with a
greater increase in bacterial burden compared to TLR2
2/2 mice
beginning on day 3 post-infection. Notable also was the complete
lack of detectable TNF in the lungs of the MyD88
2/2 mice at days
1–5 post-infection. This is not surprising given the role of MyD88
as a critical signaling adaptor in numerous pro-inflammatory
signaling pathways, including those activated via the IL-1b and
IL-18 receptors, and in other TLR signaling pathways, e.g. TLR9
Figure 4. TNF expression in the lungs of mice infected i.n. with F. tularensis LVS. (A) Groups of 3–4 mice from the indicated strains were
infected intranasally with 6,000 CFU of LVS. At day 5 post-infection, BALF was recovered from each mouse and cytokine levels quantified by BD
TM
Cytometric Bead Array (BD Biosciences, San Diego, CA). The data are expressed as the average cytokine level (+ SEM) from 3–4 individual mice.
Significant differences among groups were determined by Kruskal-Wallis ANOVA on ranks followed by Dunn’s post-hoc analysis;
*p,0.05. (B) Groups
of 2–3 B6, MyD88
2/2 and TLR2
2/2 mice were infected i.n. with 3,600 CFU of LVS or mock-infected and sacrificed after 1, 3, and 5 days post-infection.
Lung tissue cryosections were prepared at the indicated time points and stained with purified goat anti-TNF (red) followed by Rhodamine Red-X-
conjugated anti-goat Ig and analyzed by in situ immunofluorescence microscopy. Nuclei of cells (blue) were visualized via staining with
4969diamidino-2-phenylindole-dilactate (DAPI). The same sections were also stained for bacteria (green) with Alexa488-conjugated mouse anti-LVS
LPS. Representative images from 2–3 mice are shown. Magnification for all images is 4006.
doi:10.1371/journal.pone.0007920.g004
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tularensis subsp. novicida grew to higher titers in the organs of mice
depleted of IL-1-b or IL-18 by treatment with neutralizing
antibodies [25]. In that regard, however, Collazo et al. recently
reported that survival of TLR9
2/2, IL-1Rb
2/2 and IL-18
2/2
mice after i.d. LVS infection was no different than for wild-type
control mice [33]. Thus the basis for the difference in susceptibility
to infection observed between MyD88
2/2 and TLR2
2/2 mice
requires further study.
The survival studies reported herein indicate that neither TLR1
nor TLR6 is required exclusively to pair with TLR2 in recogn-
ition of F. tularensis LVS ligands. These results would appear
Figure 5. Survival rates and cytokine expression of TLR1
2/2 and TLR6
2/2 mice infected with F. tularensis LVS. (A) Survival curves are
shown for intranasal infections with LVS. The data shown were pooled from two independent experiments with the i.n. inocula and group sizes as
indicated: B6 (6,200 CFU, n=10), TLR1
2/2 (6,200 CFU, n=10), TLR6
2/2 (9,700 CFU, n=10). (B) Proteose peptone-elicited peritoneal macrophages
from B6, TLR1
2/2, and TLR6
2/2 mice were infected with LVS (MOI of 120), supernatants were collected from cultures at 4 h, and cytokines were
quantified by BD
TM Cytometric Bead Array (CBA) Mouse Inflammation Kit (BD Biosciences Pharmingen, San Diego, CA). The data are expressed as the
average cytokine level (pg/ml) (+ SEM) in triplicate culture supernatants and are representative of 2–3 independent experiments. Significant
differences among groups were determined by one-way ANOVA followed by Holm-Sidek post-hoc analysis;
*p,0.01. Cytokine and chemokine levels
in supernatants from mock-infected cells were ,20 pg/ml (data not shown).
doi:10.1371/journal.pone.0007920.g005
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abrogation of TNF secretion by dendritic cells from TLR6-
deficient mice but normal TNF secretion by TLR1-deficient cells
[39]. We have also recently compared the TNF response to LVS
by bone marrow-derived dendritic cells and have found no
difference in the response between cells derived from TLR1
2/2 or
TLR6
2/2 mice; however, the response from both were impaired
relative to wild-type control dendritic cells (unpublished data). The
reason for the discrepancy in results is not clear, but recently Re
and colleagues have demonstrated that either TLR1 or TLR6
expressed in HEK-293 cells can recognize and mediate a response
to LVS ligands [41] and the same group has recently identified
specific ligands for TLR2/TLR1 in LVS [48]. Thus, the
observation that deficiencies in either TLR1 or TLR6 have no
impact on the survival of mice whereas TLR2 deficiency has a
profound impact suggests that TLR1 and TLR6 may be
redundant in the ability to recognize F. tularensis ligands in concert
with TLR2. Interestingly, in our studies, macrophages from
TLR6
2/2 mice expressed significantly higher levels of TNF, IL-6,
and MCP-1 than wild-type macrophages. It is not known if the
absence of TLR6 leads to aberrant or increased activation through
TLR2/TLR1 or if TLR6 normally functions to negatively
regulate a signaling pathway.
Our studies and those of others [33,49,50] indicate that TLR4
plays no protective role in the host immune response to F. tularensis
infection. This has been a somewhat surprising finding since F.
tularensis is a Gram-negative bacterium and because a previous
study reported that TLR4-defective mice (C3H/HeJ strain) were
more susceptible to intradermal infection with LVS [51].
However, the LPS produced by F. tularensis has very little
endotoxin activity compared to the LPS produced by E. coli or
Salmonella species and has recently been shown to bind poorly, if at
all, to TLR4 [52–54]. Moreover, other Gram-negative bacteria
with atypical LPS have been reported to signal primarily through
TLR2 rather than TLR4 [55]. It is interesting to note that the host
inflammatory response to F. tularensis infection in the lungs of wild-
type mice appears to be significantly delayed [2,20,56], suggesting
the possibility that the absence of a potent TLR4 ligand in F.
tularensis plays an important role in immune evasion. Indeed,
recent studies have observed decreased virulence and enhanced
innate immune responses for F. tularensis subsp. novicida mutants
with altered lipid A moieties [57]. Although we have shown that
TLR2
2/2 mice are more susceptible to i.n. infection with F.
tularensis subsp. novicida, a strain with a distinct, more biologically
active LPS, and which is more highly virulent in mice than the
LVS strain [10], TLR4 does not contribute significantly to host
protection against this strain either.
TNF is well-known to play an important role in the immune
response to F. tularensis infection and TNF-deficient mice succumb
quickly to LVS infection, as do IL-12-deficient and IFN-c-
deficient mice [58–63]. Such studies support a model in which
early expression of TNF, IL-12 and IFN-c by diverse myeloid and
lymphoid cell types in response to F. tularensis infection induces
recruitment of inflammatory cells and IFN-c production primarily
from NK cells and dendritic cells [64] that in turn further activate
macrophages and dendritic cells and induce Th1 immunity. The
significant reduction in the expression of TNF by TLR2-deficient
macrophages infected in vitro and the significant reduction of TNF
expression in the lungs of TLR2
2/2 mice infected with LVS is
striking and suggests that the increased susceptibility of TLR2-
deficient mice to infection can perhaps be accounted for solely by
the impairment of TNF expression in vivo early in the infection.
However, other TLR2-dependent pro-inflammatory cytokines and
chemokines may also play important roles in the protective host
immune response as illustrated by the TLR2-dependent induction
of IL-6 and MCP-1 in infected macrophages. Although our data
do not reveal which cells harbor LVS in the lungs or which cells
are producing proinflammatory cytokines, others have shown that
alveolar macrophages, dendritic cells, and neutrophils are the
primary cells in the lung that are infected with F. tularensis [2,65].
Future studies will attempt to delineate the role of the expression of
individual cytokines by specific cell types in the TLR-dependent
host response to F. tularensis infection.
Finally, the components of F. tularensis that are responsible for
activating innate immune responses in the host are just beginning
to be identified [31,66]. TLR2 is expressed on many cell types and
has been reported to bind to a broad array of microbial
components [67], most notably lipoproteins [68], but also
peptidoglycan [35,69], and recently a bacterial porin [70].
TLR2 has also been shown to play a role in the host response
to a number of infections by both Gram-positive and Gram-
negative bacteria, including Staphylococcus aureus [71], Streptococcus
pneumonia [72], Legionella pneumophila [73,74], and Porphyromonas
gingivalis [75]; it also plays an important role in the responses to a
number of bacteria that express an atypical LPS [55]. Identifica-
tion of the TLR2 ligands responsible for activating host protective
responses to F. tularensis, as well as other possible F. tularensis
PAMPs, will be important for a complete understanding of F.
tularensis pathogenesis and therefore an important goal of future
studies.
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